Efficacy of Endovascular Treatment in Subclavian Artery Occlusive Diseases
Objective: The aim of this retrospective study is to evaluate the success and clinical results of endovascular treatment in subclavian artery occlusive diseases and to compare these results with surgical treatment methods.
Materials and Methods: Between 1994 and 2009, 14 (37.8%) women, 23′ of whom subclavian artery stenosis and/or occlusion were detected after presenting clinical symptoms and imaging methods, color Doppler ultrasonography (RDUS), Digital Subtraction Angiography (DSA) Endovascular treatment with balloon angioplasty and/or stent implantation was applied to 38 existing lesions in 37 patients, of whom 62.2% were men and their mean age was 56.4 (ranging from 22 to 82 years). After the treatment, the controls of the patients were followed up with clinical and CDUS at pre-planned times.
Results: 32 of the lesions were located on the left (84.2%) and 6 of them (15.8%) were located on the right. 7 (18.4%) cases were occlusion and 31 (81.6%) cases were stenosis. The rate of stenosis was more than 50% in CDUS and 83.2% in DSA. Technical success for stenotic lesions was 100%. Since the 3 occluded lesions could not be passed, endovascular treatment could not be applied to these patients. Therefore, the technical success for occlusions was 57%. As a complication, extravasation and thrombotic occlusion development in the proximal subclavian artery in one patient during the procedure, and a stent graft was implanted in the segment with extravasation and a separate stent was implanted in the proximal occlusion. In one patient, due to distal embolization, 5 mg t-PA infusion was administered for 1.5 hours and recanalization was achieved. In the patients who can be followed up, the primary and secondary patency rate is 100% for the early (0-3 months) and middle (3-6 months) periods, while the primary patency is 95.5% and the secondary patency is 100% for the late (6-12 months) period. found.
Conclusion: Endovascular treatment in subclavian artery occlusive diseases is technically and clinically an effective and safe alternative to surgical treatment.
Year 2019, Volume 44, Issue 2, 354 – 359, 30.06.2019
Hüseyin Tuğsan BALLI Erol AKGÜL Kairgeldy AİKİMBAEV
https://doi.org/10.17826/cumj.467033
Efficacy of Endovascular Treatment in Subclavian Artery Occlusive Diseases
Objective: The aim of this retrospective study is to evaluate the success and clinical results of endovascular treatment in subclavian artery occlusive diseases and to compare these results with surgical treatment methods.
Materials and Methods: Between 1994 and 2009, 14 (37.8%) women, 23′ of whom subclavian artery stenosis and/or occlusion were detected after presenting clinical symptoms and imaging methods, color Doppler ultrasonography (RDUS), Digital Subtraction Angiography (DSA) Endovascular treatment with balloon angioplasty and/or stent implantation was applied to 38 existing lesions in 37 patients, of whom 62.2% were men and their mean age was 56.4 (ranging from 22 to 82 years). After the treatment, the controls of the patients were followed up with clinical and CDUS at pre-planned times.
Results: 32 of the lesions were located on the left (84.2%) and 6 of them (15.8%) were located on the right. 7 (18.4%) cases were occlusion and 31 (81.6%) cases were stenosis. The rate of stenosis was more than 50% in CDUS and 83.2% in DSA. Technical success for stenotic lesions was 100%. Since the 3 occluded lesions could not be passed, endovascular treatment could not be applied to these patients. Therefore, the technical success for occlusions was 57%. As a complication, extravasation and thrombotic occlusion development in the proximal subclavian artery in one patient during the procedure, and a stent graft was implanted in the segment with extravasation and a separate stent was implanted in the proximal occlusion. In one patient, due to distal embolization, 5 mg t-PA infusion was administered for 1.5 hours and recanalization was achieved. In the patients who can be followed up, the primary and secondary patency rate is 100% for the early (0-3 months) and middle (3-6 months) periods, while the primary patency is 95.5% and the secondary patency is 100% for the late (6-12 months) period. found.
Conclusion: Endovascular treatment in subclavian artery occlusive diseases is technically and clinically an effective and safe alternative to surgical treatment.
Year 2019, Volume 44, Issue 2, 354 – 359, 30.06.2019
Hüseyin Tuğsan BALLI Erol AKGÜL Kairgeldy AİKİMBAEV
https://doi.org/10.17826/cumj.467033
Efficacy of Endovascular Treatment in Subclavian Artery Occlusive Diseases
Objective: The aim of this retrospective study is to evaluate the success and clinical results of endovascular treatment in subclavian artery occlusive diseases and to compare these results with surgical treatment methods.
Materials and Methods: Between 1994 and 2009, 14 (37.8%) women, 23′ of whom subclavian artery stenosis and/or occlusion were detected after presenting clinical symptoms and imaging methods, color Doppler ultrasonography (RDUS), Digital Subtraction Angiography (DSA) Endovascular treatment with balloon angioplasty and/or stent implantation was applied to 38 existing lesions in 37 patients, of whom 62.2% were men and their mean age was 56.4 (ranging from 22 to 82 years). After the treatment, the controls of the patients were followed up with clinical and CDUS at pre-planned times.
Results: 32 of the lesions were located on the left (84.2%) and 6 of them (15.8%) were located on the right. 7 (18.4%) cases were occlusion and 31 (81.6%) cases were stenosis. The rate of stenosis was more than 50% in CDUS and 83.2% in DSA. Technical success for stenotic lesions was 100%. Since the 3 occluded lesions could not be passed, endovascular treatment could not be applied to these patients. Therefore, the technical success for occlusions was 57%. As a complication, extravasation and thrombotic occlusion development in the proximal subclavian artery in one patient during the procedure, and a stent graft was implanted in the segment with extravasation and a separate stent was implanted in the proximal occlusion. In one patient, due to distal embolization, 5 mg t-PA infusion was administered for 1.5 hours and recanalization was achieved. In the patients who can be followed up, the primary and secondary patency rate is 100% for the early (0-3 months) and middle (3-6 months) periods, while the primary patency is 95.5% and the secondary patency is 100% for the late (6-12 months) period. found.
Conclusion: Endovascular treatment in subclavian artery occlusive diseases is technically and clinically an effective and safe alternative to surgical treatment.
Year 2019, Volume 44, Issue 2, 354 – 359, 30.06.2019
Hüseyin Tuğsan BALLI Erol AKGÜL Kairgeldy AİKİMBAEV
https://doi.org/10.17826/cumj.467033
Efficacy of Endovascular Treatment in Subclavian Artery Occlusive Diseases
Objective: The aim of this retrospective study is to evaluate the success and clinical results of endovascular treatment in subclavian artery occlusive diseases and to compare these results with surgical treatment methods.
Materials and Methods: Between 1994 and 2009, 14 (37.8%) women, 23′ of whom subclavian artery stenosis and/or occlusion were detected after presenting clinical symptoms and imaging methods, color Doppler ultrasonography (RDUS), Digital Subtraction Angiography (DSA) Endovascular treatment with balloon angioplasty and/or stent implantation was applied to 38 existing lesions in 37 patients, of whom 62.2% were men and their mean age was 56.4 (ranging from 22 to 82 years). After the treatment, the controls of the patients were followed up with clinical and CDUS at pre-planned times.
Results: 32 of the lesions were located on the left (84.2%) and 6 of them (15.8%) were located on the right. 7 (18.4%) cases were occlusion and 31 (81.6%) cases were stenosis. The rate of stenosis was more than 50% in CDUS and 83.2% in DSA. Technical success for stenotic lesions was 100%. Since the 3 occluded lesions could not be passed, endovascular treatment could not be applied to these patients. Therefore, the technical success for occlusions was 57%. As a complication, extravasation and thrombotic occlusion development in the proximal subclavian artery in one patient during the procedure, and a stent graft was implanted in the segment with extravasation and a separate stent was implanted in the proximal occlusion. In one patient, due to distal embolization, 5 mg t-PA infusion was administered for 1.5 hours and recanalization was achieved. In the patients who can be followed up, the primary and secondary patency rate is 100% for the early (0-3 months) and middle (3-6 months) periods, while the primary patency is 95.5% and the secondary patency is 100% for the late (6-12 months) period. found.
Conclusion: Endovascular treatment in subclavian artery occlusive diseases is technically and clinically an effective and safe alternative to surgical treatment.
Year 2019, Volume 44, Issue 2, 354 – 359, 30.06.2019
Hüseyin Tuğsan BALLI Erol AKGÜL Kairgeldy AİKİMBAEV
https://doi.org/10.17826/cumj.467033
